Oncolytic virotherapy is an effective cancer treatment using special viruses, capable of finding and destroying malignant tumour cells in the body. Rigvir is the first registered and still the one and only genetically unmodified virus available worldwide.
After being administered, the virus finds and infects malignant tumour cells in a process called oncotropism. The virus replicates itself in the cells of a malignant tumour destroying them in a process called oncolysis. Viruses not only destroy cancer cells but also activate the body’s natural immune system, which also targets the malignant cells.
The goal of virotherapy, not unlike that of radiation therapy and chemotherapy, is to destroy cancer cells.
Virotherapy is recognised as a safe and efficient cancer treatment method.
CANCER TREATMENT BY RIGVIR
Oncolytic virotherapy is an official, innovative, and effective cancer treatment using a special virus, which is capable of finding and destroying cells of a malignant tumor in the human body. The medicinal product is intramuscularly injected into a body.
Virotherapy takes place on an in-patient or out-patient basis, depending on the situation and patient’s health condition. The treatment takes place pursuant to tailor-made treatment protocol and in accordance with the application guidelines under the supervision of the doctor. The average treatment period is 3 years during which regular monitoring of analyses and a patient observation takes place.
Cancer virotherapy is a treatment method that is gentle to a body and has minimum side effects. The most common side effect is slightly increased body temperature (up to 37.5°C, 99.5°F) lasting one to three days.